<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_BGU_Israel skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:BGU Israel</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="header_img_div" align="center" width="100%"><H1 class="firstHeading">Team:BGU Israel</H1></DIV><DIV id="content"><DIV id="bodyContent"><DIV id="header-container"><DIV id="menu"><UL><LI><A id="home" href="https://2015.igem.org/Team:BGU_Israel">Home</A></LI><LI>Project
                            </LI><LI><A id="A3" href="https://2015.igem.org/Team:BGU_Israel/Description">Description</A></LI><LI><A href="https://2015.igem.org/Team:BGU_Israel/Design">Design</A></LI><LI><A href="https://2015.igem.org/Team:BGU_Israel/Results">Results</A></LI><LI><A href="https://2015.igem.org/Team:BGU_Israel/Experiments">Protocols</A></LI><LI><A href="https://2015.igem.org/Team:BGU_Israel/Collaborations">Collaborations</A></LI><LI><A href="https://2015.igem.org/Team:BGU_Israel/Achievements">Achievements</A></LI></UL><LI><A id="A2" href="https://2015.igem.org/Team:BGU_Israel/Team">Team</A></LI><LI><A id="A2" href="https://2015.igem.org/Team:BGU_Israel/Team">Team</A></LI><LI><A href="https://2015.igem.org/Team:BGU_Israel/Attributions">Attributions</A></LI><LI> Practices
            </LI><LI><A href="https://2015.igem.org/Team:BGU_Israel/Practices">Practices and Polices</A></LI><LI><A href="https://2015.igem.org/Team:BGU_Israel/Entrepreneurship">Entrepreneurship</A></LI><LI><A href="https://2015.igem.org/Team:BGU_Israel/Ethics">Ethics</A></LI><LI>Parts
            		</LI><LI><A href="https://2015.igem.org/Team:BGU_Israel/Parts">Team Parts</A></LI><LI><A href="https://2015.igem.org/Team:BGU_Israel/Basic_Part">Basic Parts</A></LI><LI><A href="https://2015.igem.org/Team:BGU_Israel/Part_improvement">Part Improvement</A></LI><LI><A href="https://2015.igem.org/Team:BGU_Israel/Part_Collection">Part Collection</A></LI><LI><A id="A4" href="https://2015.igem.org/Team:BGU_Israel/Notebook">Notebook</A></LI><LI><A href="https://2015.igem.org/Team:BGU_Israel/Safety">Safety</A></LI></DIV></DIV></DIV></DIV><DIV id="Div1"><DIV id="wikicontent-container"><DIV id="wikicontent"><DIV style="height: 145px; margin: 5px 0px 5px;"><TABLE style="width: 100%; border-style: hidden;"><TBODY><TR style="border-style: hidden;"><TD style="text-align: left; border-style: hidden;"><DIV align="center">Achievements</DIV></TD><TD style="text-align: left; border-style: hidden;"><DIV align="center">Project description</DIV></TD><TD style="text-align: left; border-style: hidden;"><DIV align="center">Design</DIV></TD><TD style="text-align: left; border-style: hidden;"><DIV align="center">Results</DIV></TD><TD style="text-align: left; border-style: hidden;"><DIV align="center">Practices and Polices</DIV></TD></TR></TBODY></TABLE></DIV><H2><SPAN class="mw-headline" id="PhyscoFilter_.E2.80.93_Clean_different."> The Boomerang system: synthetic machine for cancer therapy </SPAN></H2><P>Despite recent treatment advancements, cancer is still a major cause of mortality worldwide. One of the fundamental problems preventing the development of effective therapy is the difficulty to target cancer cells exclusively. 
  In Boomerang, we're engineering a genetic device based on a simple concept of AND logic gate: the activation of our CRISPR/Cas9-based system is dependent on the existence of two cancer-specific promoters that control the expression of Cas9 and gRNA, and the combination of these two will occur only in cancer cells. CRISPR/Cas9 system allows several applications of Boomerang: 1) disruption of genes essential for cancer survival; and 2) activation of suicide genes, or color proteins for cancer cell detection (e.g., for complete surgical removal).   Our system can be potentially designed according to unique characteristics of a patient's tumor, paving the way to personalized medicine. We hope that our strategy will change the approach to cancer treatments.</P></DIV></DIV></DIV></DIV><DIV id="social-footer"><DIV id="follow"><H2>Follow us:</H2></DIV><DIV id="Div3"><H2>Address:</H2><DIV align="center"><TABLE style="background-color:transparent;"><TBODY><TR><TD style="border-style: hidden;background-color:transparent;"><FONT color="white">Ben-Gurion University of the Negev 
          Ben Gurion 1, Beer Sheva 8410501, Israel
          Mail: igembgu2015@gmail.com</FONT></TD></TR></TBODY></TABLE></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>